Total Payments
$25,159
2024 Payments
$3,997
Companies
41
Transactions
1,352
Medicare Patients
6,550
Medicare Billing
$960,345
Payment Breakdown by Category
Food & Beverage$19,360 (76.9%)
Other$4,625 (18.4%)
Travel$743.05 (3.0%)
Education$431.45 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,360 | 1,341 | 76.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,625 | 1 | 18.4% |
| Travel and Lodging | $743.05 | 1 | 3.0% |
| Education | $431.45 | 9 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $5,700 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,613 | 170 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,448 | 94 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $1,267 | 94 | $0 (2024) |
| ABBVIE INC. | $1,239 | 116 | $0 (2024) |
| Alkermes, Inc. | $1,176 | 61 | $0 (2024) |
| Corium, LLC | $978.31 | 81 | $0 (2024) |
| Allergan, Inc. | $971.03 | 71 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $959.42 | 60 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $958.58 | 75 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,997 | 250 | Otsuka America Pharmaceutical, Inc. ($543.58) |
| 2023 | $9,134 | 246 | Supernus Pharmaceuticals, Inc. ($5,368) |
| 2022 | $2,991 | 215 | Ironshore Pharmaceuticals Inc. ($371.57) |
| 2021 | $2,344 | 165 | Otsuka America Pharmaceutical, Inc. ($341.51) |
| 2020 | $1,542 | 94 | Otsuka America Pharmaceutical, Inc. ($295.23) |
| 2019 | $1,601 | 125 | Otsuka America Pharmaceutical, Inc. ($382.35) |
| 2018 | $2,002 | 154 | Allergan Inc. ($379.79) |
| 2017 | $1,549 | 103 | Sunovion Pharmaceuticals Inc. ($301.32) |
All Payment Transactions
1,352 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: ADHD | ||||||
| 12/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $0.16 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: ADHD | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: CNS | ||||||
| 12/03/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: ADHD | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/25/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: ADHD | ||||||
| 11/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Narcoplepsy | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,343 | 3,758 | $408,120 | $216,695 |
| 2022 | 9 | 1,142 | 3,460 | $352,810 | $174,665 |
| 2021 | 13 | 2,108 | 5,554 | $537,642 | $282,783 |
| 2020 | 11 | 1,957 | 5,885 | $602,470 | $286,203 |
Total Patients
6,550
Total Services
18,657
Medicare Billing
$960,345
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 628 | $87,475 | $52,692 | 60.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 156 | 1,333 | $99,975 | $49,904 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 713 | $77,975 | $39,701 | 50.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 147 | 450 | $56,250 | $26,986 | 48.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 155 | 166 | $29,050 | $16,317 | 56.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 86 | 86 | $22,525 | $11,977 | 53.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 137 | 148 | $18,500 | $8,970 | 48.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 40 | 99 | $8,910 | $5,463 | 61.3% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 37 | 37 | $5,500 | $3,226 | 58.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 56 | 98 | $1,960 | $1,459 | 74.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 337 | 1,032 | $103,175 | $55,149 | 53.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 135 | 1,183 | $88,725 | $34,920 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 321 | $40,125 | $25,896 | 64.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 127 | 471 | $58,875 | $25,491 | 43.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 133 | 145 | $25,375 | $14,886 | 58.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 57 | 57 | $14,250 | $7,647 | 53.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 121 | 131 | $16,375 | $7,128 | 43.5% |
| 96130 | Evaluation of psychological test, first hour | Office | 2022 | 27 | 27 | $4,050 | $2,253 | 55.6% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 48 | 93 | $1,860 | $1,295 | 69.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 457 | 1,426 | $142,600 | $82,545 | 57.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 263 | 728 | $91,030 | $56,881 | 62.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 175 | 1,596 | $119,700 | $47,326 | 39.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 169 | 539 | $67,325 | $29,841 | 44.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 173 | 195 | $34,125 | $20,289 | 59.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 98 | 100 | $25,000 | $13,495 | 54.0% |
About John Strunk
John Strunk is a Addiction Medicine healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811983596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Strunk has received a total of $25,159 in payments from pharmaceutical and medical device companies, with $3,997 received in 2024. These payments were reported across 1,352 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($19,360).
As a Medicare-enrolled provider, Strunk has provided services to 6,550 Medicare beneficiaries, totaling 18,657 services with total Medicare billing of $960,345. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Psychiatry, Psychiatry
- Location Dothan, AL
- Active Since 09/27/2005
- Last Updated 04/04/2025
- Taxonomy Code 2084A0401X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811983596
Products in Payments
- QELBREE (Drug) $5,633
- REXULTI (Drug) $2,003
- VRAYLAR (Drug) $1,948
- JORNAY PM (Drug) $1,150
- NUEDEXTA (Drug) $1,045
- INGREZZA (Drug) $959.42
- ARISTADA (Drug) $873.21
- AUSTEDO (Drug) $764.30
- Dyanavel XR (Drug) $761.74
- Azstarys (Drug) $744.71
- ABILIFY MAINTENA (Drug) $680.92
- Adzenys XR-ODT (Drug) $571.44
- LATUDA (Drug) $531.83
- QUVIVIQ (Drug) $493.83
- FANAPT (Drug) $475.56
- Wakix (Drug) $438.54
- CAPLYTA (Drug) $432.28
- Trintellix (Drug) $415.62
- TRINTELLIX (Drug) $360.82
- BELSOMRA (Drug) $346.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.